Author Correction: Ablation of CD8α

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 May 2020
Historique:
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 28 5 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-65653-2 PMID: 32457341 PMC: PMC7250898
pubmed: 32457341
doi: 10.1038/s41598-020-65653-2
pii: 10.1038/s41598-020-65653-2
pmc: PMC7250898
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

8747

Commentaires et corrections

Type : ErratumFor

Auteurs

Bart Legein (B)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Edith M Janssen (EM)

Division of Immunobiology, Cincinnati Children's Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.

Thomas L Theelen (TL)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Marion J Gijbels (MJ)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.
Experimental Vascular Biology, Dept. of Medical Biochemistry, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.

Joep Walraven (J)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Jared S Klarquist (JS)

Division of Immunobiology, Cincinnati Children's Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.

Cassandra M Hennies (CM)

Division of Immunobiology, Cincinnati Children's Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.

Kristiaan Wouters (K)

Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Tom T P Seijkens (TTP)

Experimental Vascular Biology, Dept. of Medical Biochemistry, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.

Erwin Wijnands (E)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Judith C Sluimer (JC)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Esther Lutgens (E)

Experimental Vascular Biology, Dept. of Medical Biochemistry, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.
Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University (LMU), Munich, Germany.

Martin Zenke (M)

Institute for Biomedical Engineering, Dept. of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.

Kai Hildner (K)

Medical Immunology, Universitatsklinikum Erlangen, Erlangen, Germany.

Erik A L Biessen (EAL)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands.

Lieve Temmerman (L)

Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands. lieve.temmerman@mumc.nl.

Classifications MeSH